No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr19:35912600-35938000 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
2 |
chr19:35920600-35930000 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
3 |
chr19:35923800-35930000 |
Enhancers |
Fetal Muscle Leg |
muscle
|
4 |
chr19:35924400-35928600 |
Enhancers |
Fetal Kidney |
kidney
|
5 |
chr19:35924400-35929600 |
Enhancers |
Fetal Adrenal Gland |
Adrenal Gland
|
6 |
chr19:35924800-35927600 |
Enhancers |
Fetal Heart |
heart
|
7 |
chr19:35925200-35927600 |
Enhancers |
Stomach Mucosa |
stomach
|
8 |
chr19:35925400-35929600 |
Enhancers |
Fetal Intestine Large |
intestine
|
9 |
chr19:35925600-35927600 |
Weak transcription |
Brain Inferior Temporal Lobe |
brain
|
10 |
chr19:35925600-35927600 |
Enhancers |
Rectal Mucosa Donor 31 |
rectum
|
11 |
chr19:35925600-35927800 |
Enhancers |
Brain Anterior Caudate |
brain
|
12 |
chr19:35925600-35927800 |
Weak transcription |
Spleen |
Spleen
|
13 |
chr19:35925600-35928200 |
Enhancers |
Brain Cingulate Gyrus |
brain
|
14 |
chr19:35925600-35928800 |
Enhancers |
Fetal Intestine Small |
intestine
|
15 |
chr19:35925600-35930000 |
Enhancers |
Fetal Stomach |
stomach
|
16 |
chr19:35926000-35927600 |
Weak transcription |
Right Atrium |
heart
|
17 |
chr19:35926000-35928800 |
Flanking Active TSS |
Primary neutrophils fromperipheralblood |
blood
|
18 |
chr19:35926000-35929000 |
Enhancers |
Small Intestine |
intestine
|
19 |
chr19:35926200-35927800 |
Enhancers |
Colonic Mucosa |
Colon
|
20 |
chr19:35926200-35928000 |
Flanking Active TSS |
Primary B cells from cord blood |
blood
|
21 |
chr19:35926200-35928600 |
Enhancers |
Liver |
Liver
|
22 |
chr19:35926200-35929600 |
Enhancers |
Lung |
lung
|
23 |
chr19:35926200-35930000 |
Enhancers |
Ovary |
ovary
|
24 |
chr19:35926200-35930000 |
Enhancers |
Pancreas |
Pancrea
|
25 |
chr19:35926400-35928200 |
Enhancers |
Colon Smooth Muscle |
Colon
|
26 |
chr19:35926400-35928600 |
Bivalent Enhancer |
Skeletal Muscle Female |
skeletal muscle
|
27 |
chr19:35926400-35928600 |
Flanking Active TSS |
Monocytes-CD14+_RO01746 |
blood
|
28 |
chr19:35926400-35928800 |
Enhancers |
Primary Natural Killer cells fromperipheralblood |
blood
|
29 |
chr19:35926400-35928800 |
Enhancers |
Sigmoid Colon |
Sigmoid Colon
|
30 |
chr19:35926800-35927600 |
Bivalent Enhancer |
Skeletal Muscle Male |
skeletal muscle
|
31 |
chr19:35926800-35927800 |
Enhancers |
Placenta |
Placenta
|
32 |
chr19:35926800-35928000 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
33 |
chr19:35926800-35928000 |
Enhancers |
Primary B cells from peripheral blood |
blood
|
34 |
chr19:35926800-35928000 |
Enhancers |
Primary T helper cells PMA-I stimulated |
--
|
35 |
chr19:35926800-35928000 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
36 |
chr19:35926800-35928000 |
Enhancers |
Primary mononuclear cells fromperipheralblood |
Blood
|
37 |
chr19:35926800-35928200 |
Flanking Active TSS |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
38 |
chr19:35926800-35928200 |
Flanking Active TSS |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
39 |
chr19:35926800-35928400 |
Flanking Active TSS |
Duodenum Smooth Muscle |
Duodenum
|
40 |
chr19:35926800-35928400 |
Enhancers |
Fetal Brain Male |
brain
|
41 |
chr19:35926800-35928400 |
Enhancers |
Gastric |
stomach
|
42 |
chr19:35926800-35928800 |
Enhancers |
Esophagus |
oesophagus
|
43 |
chr19:35926800-35928800 |
Enhancers |
Left Ventricle |
heart
|
44 |
chr19:35926800-35929600 |
Enhancers |
Right Ventricle |
heart
|
45 |
chr19:35927000-35927600 |
Enhancers |
Hela-S3 |
cervix
|
46 |
chr19:35927000-35927800 |
Flanking Active TSS |
GM12878-XiMat |
blood
|
47 |
chr19:35927000-35927800 |
Bivalent Enhancer |
HepG2 |
liver
|
48 |
chr19:35927000-35928000 |
Flanking Active TSS |
Primary hematopoietic stem cells short term culture |
blood
|
49 |
chr19:35927000-35928000 |
Enhancers |
Primary T helper naive cells from peripheral blood |
blood
|
50 |
chr19:35927000-35928000 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|